Cytokinetics | CYTK - Current Assets


Cytokinetics reported $977.35M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.08B 115.87M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cytokinetics USD 977.35M 90.81M Sep/2025
Eisai JPY 790.7B 27.55B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Exelixis USD 1.4B 221.5M Sep/2025
Geron USD 522.34M 16.75M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Ligand Pharmaceuticals USD 753.92M 400.98M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Regeneron Pharmaceuticals USD 17.98B 1.12B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025